Podocytopathies associated with familial partial lipodystrophy due to LMNA variants: report of two cases

被引:0
|
作者
Morguetti, Maria Julia [1 ]
Neves, Precil Diego Miranda de Menezes [2 ]
Korkes, Ilana [1 ]
Padilha, Wallace Stwart Carvalho [3 ]
Jorge, Lecticia Barbosa [4 ]
Watanabe, Andreia [5 ]
Watanabe, Elieser Hitoshi [2 ]
Malheiros, Denise Maria Avancini Costa [6 ]
Noronha, Irene de Lourdes [4 ]
Dib, Sergio Atala [1 ]
Onuchic, Luiz Fernando [7 ]
Moises, Regina S. [1 ]
机构
[1] Univ Fed Sao Paulo, Div Endocrinol, Escola Paulista Med, Sao Paulo, SP, Brazil
[2] Univ Sao Paulo, Fac Med, Divisoes Nefrol & Med Mol, Sao Paulo, SP, Brazil
[3] Univ Fed Sao Paulo, Escola Paulista Med, Div Nefrol, Sao Paulo, SP, Brazil
[4] Univ Sao Paulo, Fac Med, Div Nefrol, Sao Paulo, SP, Brazil
[5] Univ Sao Paulo, Fac Med, Div Nefrol Pediat & Med Mol, Sao Paulo, SP, Brazil
[6] Univ Sao Paulo, Fac Med, Dept Patol, Sao Paulo, SP, Brazil
[7] Univ Sao Paulo, Fac Med, Dept Clin Med, Sao Paulo, SP, Brazil
来源
关键词
ACQUIRED PARTIAL LIPODYSTROPHY; PHENOTYPIC DIVERSITY; LAMIN A/C; LMNA; GLOMERULOSCLEROSIS; MUTATION; DISEASE;
D O I
10.20945/2359-4292-2023-0204
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Lipodystrophies are characterized by complete or selective loss of adipose tissue and can be acquired or inherited. Familial partial lipodystrophy (FPLD) is a hereditary lipodystrophy commonly caused by mutations in the LMNA gene. Herein, we report two cases of FPLD associated with podocytopathies. Patient 1 was diagnosed with FPLD associated with the heterozygous p.Arg482Trp variant in LMNA and had normal glucose tolerance and hyperinsulinemia. During follow-up, she developed nephroticrange proteinuria. Renal biopsy was consistent with minimal change disease. Patient 2 was diagnosed with FPLD associated with a de novo heterozygous p.Arg349Trp variant in LMNA . Microalbuminuria progressed to macroalbuminuria within 6 years and to nephrotic range proteinuria in the last year. He remained without diabetes and with hyperinsulinemia. Renal biopsy revealed focal segmental glomerulosclerosis not otherwise specified. This report provides further evidence of variable features of lipodystrophy associated with LMNA variants and the importance of long-term follow-up with evaluation of kidney dysfunction.
引用
收藏
页数:5
相关论文
共 50 条
  • [31] The role of LMNA in adipose: a novel mouse model of lipodystrophy based on the Dunnigan-type familial partial lipodystrophy mutation
    Wojtanik, Kari M.
    Edgemon, Keith
    Viswanadha, Srikant
    Lindsey, Brigette
    Haluzik, Martin
    Chen, Weiping
    Poy, George
    Reitman, Marc
    Londos, Constantine
    JOURNAL OF LIPID RESEARCH, 2009, 50 (06) : 1068 - 1079
  • [32] Variable Expressivity in Type 2 Familial Partial Lipodystrophy Related to R482 and N466 Variants in the LMNA Gene
    Araujo-Vilar, David
    Sanchez-Iglesias, Sofia
    Castro, Ana I.
    Cobelo-Gomez, Silvia
    Hermida-Ameijeiras, Alvaro
    Rodriguez-Carnero, Gemma
    Casanueva, Felipe F.
    Fernandez-Pombo, Antia
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (06) : 1 - 9
  • [33] Dyslipemia in familial partial lipodystrophy caused by an R482W mutation in the LMNA gene
    Schmidt, HHJ
    Genschel, J
    Baier, P
    Schmidt, M
    Ockenga, J
    Tietge, UJF
    Pröpsting, M
    Büttner, C
    Manns, MP
    Lochs, H
    Brabant, G
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (05): : 2289 - 2295
  • [34] Breast augmentation in Familial Partial Lipodystrophy: A case report
    Hughes, Juliana M. F.
    Stephen, Christopher
    Johnson, Andrew B.
    Wilson, Sherif
    JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY, 2011, 64 (05): : E121 - E124
  • [35] Patients with familial partial lipodystrophy of the dunnigan type due to a LMNA R482W mutation show muscular and cardiac abnormalities
    Vantyghem, MC
    Pigny, P
    Maurage, CA
    Rouaix-Emery, N
    Stojkovic, T
    Cuisset, JM
    Millaire, A
    Lascols, O
    Vermersch, P
    Wemeau, JL
    Capeau, J
    Vigouroux, C
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (11): : 5337 - 5346
  • [36] A case report of Type 2 Familial Partial Lipodystrophy
    Araujo-Vilar, David
    Fernandez-Pombo, Antia
    Hermida-Ameijeiras, Alvaro
    Sanchez-Iglesias, Sofia
    GALICIA CLINICA, 2021, 82 : S33 - S35
  • [37] Gain of Function NOTCH3 Variants Cause Familial Partial Lipodystrophy Due to Activation of Senescence Pathways
    Garg, Abhimanyu
    Xing, Chao
    Agarwal, Anil K.
    Westfall, Aundrea K.
    Tomchick, Diana R.
    Zhang, Xunzhi
    Xing, Michelle
    Brown, Rebecca J.
    DIABETES, 2025, 74 (03)
  • [38] Histological and molecular features of lipomatous and nonlipomatous adipose tissue in familial partial lipodystrophy caused by LMNA mutations
    Araujo-Vilar, D.
    Victoria, B.
    Gonzalez-Mendez, B.
    Barreiro, F.
    Fernandez-Rodriguez, B.
    Cereijo, R.
    Gallego-Escuredo, J. M.
    Villarroya, F.
    Paneda-Menendez, A.
    CLINICAL ENDOCRINOLOGY, 2012, 76 (06) : 816 - 824
  • [39] Familial partial lipodystrophy associated with the heterozygous LMNA mutation 1445G>A (Arg482Gln) in a Polish family
    Drac, Hanna
    Madej-Pilarczyk, Agnieszka
    Gospodarczyk-Szot, Krystyna
    Gowel, Matgorzata
    Kwiecinski, Hubert
    Hausmanowa-Petrusewicz, Irena
    NEUROLOGIA I NEUROCHIRURGIA POLSKA, 2010, 44 (03) : 291 - 296
  • [40] The heterozygous LMNA mutation p.R471G causes a variable phenotype with features of two types of familial partial lipodystrophy
    Muschke, Petra
    Koelsch, Uwe
    Jakubiczka, Sibylle
    Wieland, Ilse
    Brune, Thomas
    Wieacker, Peter
    AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2007, 143A (23) : 2810 - 2814